Americas was Nu Skin Enterprises’s largest segment in fiscal 2025, bringing in $282.98M of $1.49B (19%).
| Segment | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|
| Mainland China | $360.39M | $298.08M | $235.24M | $195.55M | ||||
| Americas | $508.54M | $398.22M | $322.52M | $282.98M | ||||
| Consists Of Canada, Latin America & The United States | — | — | — | — | ||||
| Consists Of Australia, Canada, Latin America, New Caledonia, New Zealand & The United States | — | — | — | — | ||||
| Consists Of Brunei, French Polynesia, Indonesia, Malaysia, The Philippines, Singapore, Thailand & Vietnam | — | — | — | — | ||||
| Southeast Asia/Pacific | $344.41M | $267.21M | $244.85M | $209.80M | ||||
| Consists Of Australia, Indonesia, Malaysia, New Zealand, The Philippines, Singapore, Thailand & Vietnam | — | — | — | — | ||||
| South Korea | $268.71M | $236.10M | $163.71M | $130.22M | ||||
| Japan | $224.90M | $207.83M | $181.56M | $174.36M | ||||
| Europe Africa | $204.28M | $192.35M | $164.16M | $150.15M | ||||
| Consists Of Europe & Africa | — | — | — | — | ||||
| Consists Of Europe, Middle East & Africa | — | — | — | — | ||||
| The Company Explores New Areas Of Synergistic & Adjacent Growth Through Their Business Arm Known As Rhyz Inc. The Rhyz Businesses, Which Are Reported In Two Segments, Primarily Consist Of Consumer, Technology And Manufacturing Companies | — | — | — | — | ||||
| Manufacturing | $149.46M | $181.40M | $201.43M | $205.79M | ||||
| The Manufacturing Segment Of Rhyz Includes Manufacturing & Packaging Subsidiaries The Company Has Acquired | — | — | — | — | ||||
| The Manufacturing Segment Includes The Manufacturing & Packaging Subsidiaries Acquired By The Company In The First Quarter Of 2018 | — | — | — | — | ||||
| Hong Kong/Taiwan | $157.20M | $153.59M | $130.61M | $117.38M | ||||
| Consists Of Hong Kong & Taiwan | — | — | — | — | ||||
| The Rhyz Investments Segment Consists Of Three Investment Segments -Manufacturing, Grow Tech & Rhyz Other | — | — | — | — | ||||
| Rhyz Other | $3.83M | $35.21M | $85.19M | $17.79M | ||||
| The Rhyz Other Segment Includes Other Investments By The Company'S Rhyz Business Arm | — | — | — | — | ||||
| Other | — | — | — | — | ||||
| Nu Skin | $3.96M | -$858.00K | $2.83M | $1.14M | ||||
| The Grow Tech Segment Focuses On A Long-Term Strategy For Consistently Sourcing Pure, Safe & Sustainable Ingredients For Use In The Company'S Products, While Also Exploring Applications In Other Industries | — | — | — | — | ||||
| Total | $2.23B | $1.97B | $1.73B | $1.49B |
Nu Skin Enterprises brought in $1.49B from its 10 segments in fiscal 2025, the year ended December 31, 2025. That was down 14.3% from $1.73B in fiscal 2024. Americas was the largest at $282.98M (19.1%), ahead of Southeast Asia/Pacific at $209.80M (14.1%) and Manufacturing at $205.79M (13.9%). The other seven segments brought in $786.59M combined.
Compared with fiscal 2024, Manufacturing grew fastest, up 2.2% to $205.79M, while South Korea fell the most, down 20.5% to $130.22M. From fiscal 2022 to 2025, combined revenue from these segments fell from $2.23B to $1.49B, a compound annual decline of 12.6%. Americas' share of the total fell from 22.8% to 19.1%.
Wellness Products Developed & Distributed Under The Pharmanex Brand was Nu Skin Enterprises’s largest revenue line in fiscal 2025, bringing in $689.06M of $1.49B (46%).
| Products and Services | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Personal Care Products Developed & Distributed Under The Nu Skin Brand | — | — | — | — | |||||||||||||
| The Product Line For Premium-Quality Personal Care Products | — | — | — | — | |||||||||||||
| The Name Of The Product Line For Which The Entity Reported Revenue From External Customers During The Period | — | — | — | — | |||||||||||||
| Nu Skin | — | — | — | — | |||||||||||||
| Beauty | $1.07B | $858.63M | $681.77M | $568.11M | |||||||||||||
| Beauty Products Developed & Distributed Under The Nu Skin Brand | — | — | — | — | |||||||||||||
| The Product Line For Science-Based Nutritional Supplements | — | — | — | — | |||||||||||||
| Pharmanex | — | — | — | — | |||||||||||||
| Wellness Products Developed & Distributed Under The Pharmanex Brand | $992.34M | $886.09M | $757.22M | $689.06M | |||||||||||||
| Other | $163.61M | $224.41M | $293.10M | $227.98M | |||||||||||||
| Other Products & Services, Including Household Products And Technology Services | — | — | — | — | |||||||||||||
| Other Product Lines For Which The Entity Reported Revenue From External Customers During The Period | — | — | — | — | |||||||||||||
| Other Product Lines | — | — | — | — | |||||||||||||
| Total | $2.23B | $1.97B | $1.73B | $1.49B |
Nu Skin Enterprises brought in $1.49B from its three revenue lines in fiscal 2025, the year ended December 31, 2025. That was down 14.3% from $1.73B in fiscal 2024. Wellness Products Developed & Distributed Under The Pharmanex Brand was the largest at $689.06M (46.4%), ahead of Beauty at $568.11M (38.3%) and Other at $227.98M (15.4%).
Compared with fiscal 2024, every revenue line above 2% of revenue shrank. Wellness Products Developed & Distributed Under The Pharmanex Brand held up best, down 9.0% to $689.06M, and Other fell the most, down 22.2% to $227.98M. From fiscal 2022 to 2025, combined revenue from these revenue lines fell from $2.23B to $1.49B, a compound annual decline of 12.6%. Wellness Products Developed & Distributed Under The Pharmanex Brand's share of the total rose from 44.6% to 46.4%.
Nu Skin Enterprises (NUS) reports its revenue by segment and by products and services. In fiscal 2025, Americas was its largest segment, bringing in $282.98M (19.1% of the total), followed by Southeast Asia/Pacific at $209.80M (14.1%).
Americas was Nu Skin Enterprises' largest segment in fiscal 2025, bringing in $282.98M, or 19.1% of the $1.49B total across its 10 segments.
Wellness Products Developed & Distributed Under The Pharmanex Brand was Nu Skin Enterprises' largest revenue line in fiscal 2025, bringing in $689.06M, or 46.4% of the $1.49B total across its three revenue lines.
Among Nu Skin Enterprises' segments that make up at least 2% of revenue, Manufacturing grew fastest in fiscal 2025, up 2.2% from $201.43M to $205.79M.
Every figure comes from Nu Skin Enterprises' annual financial filings, as reported. Each line keeps the name Nu Skin Enterprises gives it, and years follow its fiscal calendar.
Nu Skin Enterprises' revenue by segment goes back to fiscal 2018, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.